CO4700444A1 - Nuevas criptoficinas a partir de la sintesis - Google Patents

Nuevas criptoficinas a partir de la sintesis

Info

Publication number
CO4700444A1
CO4700444A1 CO96010869A CO96010869A CO4700444A1 CO 4700444 A1 CO4700444 A1 CO 4700444A1 CO 96010869 A CO96010869 A CO 96010869A CO 96010869 A CO96010869 A CO 96010869A CO 4700444 A1 CO4700444 A1 CO 4700444A1
Authority
CO
Colombia
Prior art keywords
lower alkyl
alkyl group
ring
linked
group
Prior art date
Application number
CO96010869A
Other languages
English (en)
Spanish (es)
Inventor
Richard E Moore
Marcus A Tius
Russell A Barrow
Jian Liang
Thomas H Corbett
Frederick A Valeriote
Original Assignee
Univ Hawaii
Univ Wayne State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/400,057 external-priority patent/US6013626A/en
Application filed by Univ Hawaii, Univ Wayne State filed Critical Univ Hawaii
Publication of CO4700444A1 publication Critical patent/CO4700444A1/es

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CO96010869A 1995-03-07 1996-03-06 Nuevas criptoficinas a partir de la sintesis CO4700444A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/400,057 US6013626A (en) 1993-12-21 1995-03-07 Cryptophycins from synthesis

Publications (1)

Publication Number Publication Date
CO4700444A1 true CO4700444A1 (es) 1998-12-29

Family

ID=23582070

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96010869A CO4700444A1 (es) 1995-03-07 1996-03-06 Nuevas criptoficinas a partir de la sintesis

Country Status (10)

Country Link
AR (1) AR003111A1 (https=)
BR (1) BR9600952A (https=)
CO (1) CO4700444A1 (https=)
IL (1) IL117302A (https=)
IN (1) IN185695B (https=)
PE (1) PE43497A1 (https=)
RU (1) RU2195458C2 (https=)
TR (1) TR199600191A2 (https=)
TW (1) TW458972B (https=)
ZA (1) ZA961745B (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0358418B1 (en) * 1988-09-05 1992-12-16 Sankyo Company Limited Cyclic peptide, its preparation and its use in the treatment of cardiovascular disorders
HUT73493A (en) * 1990-01-16 1996-08-28 Orszagos Frederic Joliot Curie Salts and complexes of n,n`-bis(dicarboxy-methyl)-1,4,10,13-tetraoxa-7,16-diaza-cyclooctadekane derivatives, ad pharmaceutical compositions containing them
SU1726475A1 (ru) * 1990-01-18 1992-04-15 Днепропетровский Центр Научно-Технического Творчества "Импульс" 1,12-Диаза-2,5,8,11,15-пентаоксациклогептадекан и способ его получени

Also Published As

Publication number Publication date
IN185695B (https=) 2001-04-07
RU2195458C2 (ru) 2002-12-27
PE43497A1 (es) 1997-10-11
IL117302A0 (en) 1996-06-18
ZA961745B (en) 1997-10-06
BR9600952A (pt) 1997-12-30
IL117302A (en) 2005-03-20
AR003111A1 (es) 1998-07-08
TW458972B (en) 2001-10-11
TR199600191A2 (tr) 1996-10-21

Similar Documents

Publication Publication Date Title
ZA997767B (en) Method for producing L-amino acid.
ES2067500T3 (es) 1-indolilalquil-4-(piridinil-sustituidas)piperazinas.
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
LU91564I2 (fr) Combinaison comprenant de l'aliskiren, comme base libre ou comme un de ses sels pharmaceutiquement acceptables, et de l'hydrochlorothiazide ou un de ses sels pharmaceutiquement acceptables-Rasilez HCT
GT199600026A (es) Isotiazolonas
DE60039291D1 (de) Camptothecinanaloge und deren zubereitungsmethoden
EP0982988A4 (en) IN KEY PURE ZONULIN AS A PHYSIOLOGICAL MODULATOR OF "TIGHT JUNCTIONS" IN MAMMALS
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
EE200000048A (et) Uudsed ühendid
ATE251613T1 (de) Pyrimidinonderivate zur behandlung von atheroscleros
ES2165346T3 (es) Analogos de 10,11-metilendioxi-20(rs)-camptotecina y 10,11-metilendioxi-20(s)-camptotecina.
DK1161521T3 (da) Transplantation af hæmatopoietiske celler
PT98422A (pt) Processo de fabricacao d vaterite, de um derivado calcio, de mistura de vaterites e de vaterite revestida
ES2042534T3 (es) Un proceso para la preparacion de una preparacion topica en forma de un hidrogel.
ES507994A0 (es) Un procedimiento para la preparacion de un compuesto de quinazolina.
HRP20030002A2 (en) STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
CO4700444A1 (es) Nuevas criptoficinas a partir de la sintesis
FR2643076B1 (fr) Carboxyalkyl-ethers de la 2-amino-7-hydroxytetraline
DE69704731D1 (de) Cryptophycinderivate und ihre Verwendung als antimikrotubuli Mittel
ES8504109A1 (es) Procedimiento de producir compuestos para el tratamiento de la hipertension
MY122667A (en) Benzofuran derivatives
DE59709066D1 (de) Mittel zur dauerhaften Verformung von menschlichen Haaren
SV2002000573A (es) Proceso para preparar 2-(4-piridil) amino-6- dialquiloxifenil-pirido[2,3-d] pirimidin-7-onas
MXPA02001861A (es) Nuevos inhbidores de la integrina alfav beta3.
DE69531627D1 (de) Humane hypertrophe chrondrozyten zelllinien